Considerations for Starting Up Your COVID-19 Study Quickly

When developing and testing potential COVID-19 therapies in patient populations, time is of the utmost importance. Study start-up can make or break any clinical trial timeline, but with COVID-19 research, startup must be efficient, while still taking into account the complexities of this uncertain research landscape. Based on our work with sponsors who have been starting up COVID-related studies, we can provide recommendations on ways to shave time from your startup timelines and set your program up for success from the beginning.